In contrast, TZDs were reported to stimulate VEGF expression in several cell types [56] and to increase its plasma level in type 2 diabetic patients [57], therefore suggesting that they could counterbalance the impact of their anti-inflammatory effect on the formation of new vessels. This evidence concerns the gene VEGFA and type 2 diabetes mellitus.